Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NewCardio, Inc. (NWCI)
Branchburg, NJ, US
NewCardio, Inc. is a company dedicated to cardiac diagnostics and related services. Its primary objective is the research, creation, and market introduction of exclusive software platform technologies. These innovations are designed for two main applications: the non-invasive diagnosis and continuous monitoring of cardiovascular diseases (CVD), and the assessment of cardiac safety for experimental drugs. The company's underlying technology analyzes the heart's electrical activity in real-time and in three dimensions, using data gathered from the body's surface via standard 12-lead electrocardiogram (ECG) electrodes. NewCardio is also actively developing several products. QTinno, for instance, is an automated solution for cardiac safety, utilizing algorithms to automatically measure, analyze, and report on collected ECGs, thereby streamlining traditional manual or semi-automated methods. Another product, CardioBip, is a mobile ECG system for remote transmission, comprising a portable recording and transmitting device along with web-based software that receives, processes, and interprets the data. Furthermore, the company is progressing with my3KG, a software application intended to provide a comprehensive method for evaluating cardiac electrical activity across both time and space. NewCardio, Inc. was founded in 2004 and is headquartered in Branchburg, New Jersey.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -90.00% | -80.00% | -99.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%— Q3'11: -90.0% (vs Q3'10)
-
EPS growth Medical - Devices: +28.5%+9.1% Q3'11: +12.5% (vs Q3'10)
-
FCF margin FCF growth · Medical - Devices: +30.9%-4,504.4% Q3'11: -3,693.0% (vs Q3'10)
-
EBIT margin Medical - Devices: +6.2%-3,674.8% Q3'11: -21,845.6% (vs Q3'10)
-
ROIC Medical - Devices: +3.3%— Q3'11: +525.1% (vs Q3'10)
-
Share dilution Medical - Devices: 0.0%+20.7% Q3'11: +10.3% (vs Q3'10)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.32× Q3'11: -0.46× (vs Q3'10)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008-03-18 | KROLL MARK W | Director | A-Award | A | Stock Option (right to buy) | 400,000 | 2.05 | 820.0K | 400,000 | — | ↗ |
| 2003-06-30 | EINHORN DAVID | 10% Owner | J-Other | A | Common Stock Warrant (right to buy) | 1 | 0.01 | 0.01 | 5,362,243 | — | ↗ |
| 2003-06-26 | EINHORN DAVID | 10% Owner | J-Other | A | Common Stock Warrant (right to buy) | 1 | 0.01 | 0.01 | 5,292,557 | — | ↗ |
| 2003-06-06 | EINHORN DAVID | 10% Owner | P-Purchase | A | Common Stock Warrant (right to buy) | 1 | 0.01 | 0.01 | 7,175,937 | — | ↗ |
| 2002-12-31 | EINHORN DAVID | 10% Owner | J-Other | A | Common Stock Warrant (right to buy) | 1 | 0.01 | 0.01 | 7,082,007 | — | ↗ |
| 2002-11-15 | EINHORN DAVID | 10% Owner | S-Sale | A | Common Stock Warrant (right to buy) | 6,300 | 0.01 | 63.00 | 6,347,321 | — | ↗ |
| 2002-10-15 | FARALLON PARTNERS L L C/CA | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 59 | 0.01 | 0.59 | 5,135 | — | ↗ |
| 2002-10-15 | FARALLON CAPITAL MANAGEMENT LLC | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 445 | 0.01 | 4.45 | 38,104 | — | ↗ |
| 2002-09-15 | FARALLON PARTNERS L L C/CA | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 320 | 0.01 | 3.20 | 37,659 | — | ↗ |
| 2002-09-15 | FARALLON CAPITAL MANAGEMENT LLC | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 323 | 0.01 | 3.23 | 34,723 | — | ↗ |
| 2002-08-15 | FARALLON PARTNERS L L C/CA | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 43 | 0.01 | 0.43 | 5,951 | — | ↗ |
| 2002-08-15 | FARALLON CAPITAL MANAGEMENT LLC | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 1,337 | 0.01 | 13.37 | 155,448 | — | ↗ |
| 2002-07-15 | FARALLON PARTNERS L L C/CA | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 33 | 0.01 | 0.33 | 5,908 | — | ↗ |
| 2002-07-15 | FARALLON CAPITAL MANAGEMENT LLC | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 227 | 0.01 | 2.27 | 37,024 | — | ↗ |
| 2002-06-19 | EINHORN DAVID | 10% Owner | J-Other | A | Common Stock Warrant (right to buy) | 1 | 0.01 | 0.01 | 2,833,564 | — | ↗ |
| 2002-06-15 | FARALLON PARTNERS L L C/CA | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 66 | 0.01 | 0.66 | 18,051 | — | ↗ |
| 2002-06-15 | FARALLON CAPITAL MANAGEMENT LLC | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 138 | 0.01 | 1.38 | 32,306 | — | ↗ |
| 2002-03-15 | FARALLON PARTNERS L L C/CA | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 137 | 0.01 | 1.37 | 32,168 | — | ↗ |
| 2002-03-15 | FARALLON CAPITAL MANAGEMENT LLC | 10% Owner | J-Other | A | Common Stock Warrants (Right to buy) | 3 | 0.01 | 0.03 | 915 | — | ↗ |
| 2001-06-19 | EINHORN DAVID | 10% Owner | P-Purchase | A | Common Stock Warrant (right to buy) | 6,100 | 0.01 | 61.00 | 2,146,150 | — | ↗ |
| 2001-01-17 | EINHORN DAVID | 10% Owner | — | I | Common Stock Warrants (right to buy) | 1,548,350 | 0.01 | 15.5K | 0 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Greg Sadowski | Chief Operating Officer | — | male |
| Jess Emery Jones | Chief Executive Officer & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NWCI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
